Sapporo, Japan

Junji Kato

USPTO Granted Patents = 6 

 


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Sapporo, JP (1998 - 2014)
  • Hokkaido, JP (2001 - 2017)

Company Filing History:


Years Active: 1998-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Junji Kato: A Pioneer in Pharmaceutical Development

Introduction

Junji Kato is a notable inventor based in Sapporo, Japan, recognized for his contributions to pharmaceutical innovations. With a total of 6 patents, Kato has made significant strides in developing drug delivery systems and therapeutic methods that target specific diseases.

Latest Patents

Kato's latest patents include a combined pharmaceutical preparation that focuses on treating diseases associated with target cells. This invention involves a first component containing a ligand for a polyspecific lectin in reticuloendothelial cells, paired with a second component that may include a carrier or medicament. Additionally, he has developed a drug carrier specifically designed to inhibit fibrosis. This carrier utilizes a retinoid derivative or vitamin A analog to deliver therapeutic agents directly to astrocytes, thereby minimizing side effects while effectively treating astrocyte-related diseases.

Career Highlights

Throughout his career, Junji Kato has worked with prominent companies such as Nitto Denko Corporation and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Kato has collaborated with several professionals in the field, including Yoshiro Niitsu and Yasushi Sato. These partnerships have enhanced his research and innovation efforts, leading to the development of impactful pharmaceutical solutions.

Conclusion

Junji Kato's work exemplifies the importance of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…